ライフサイエンスコーパス: a pressing need for

1 There is a pressing need for 5-D image analysis and visualization

2 There is thus a pressing need for a deeper understanding of the underl

3 There is a pressing need for a phase III trial of thyroid hormone

4 each with its own inherent limitations, and a pressing need for a safe, repeatable, inexpensive, and

5 itical and supercritical technology there is a pressing need for a simple and inexpensive sensor that

6 There is a pressing need for a vaccine for respiratory syncytial

7 marine and freshwater ecosystems highlights a pressing need for adequate and comparable detection me

8 ility to prevent chronic rejection, there is a pressing need for alternative strategies to control al

9 There is a pressing need for an effective, safe oral drug for bot

10 However, there is still a pressing need for an in vitro model of HIV latency in

11 Hence, there is a pressing need for an increased research effort to deve

12 -throughput characterization of NP, there is a pressing need for an infrastructure to enable sharing

13 ons pose a major health threat, and there is a pressing need for antibiofilm agents.

14 icular transport and drug delivery, there is a pressing need for artificial vesicles with controlled

15 e sequencing of complete genomes has created a pressing need for automated annotation of gene functio

16 There is a pressing need for better designed studies to assess th

17 There is a pressing need for blood pressure-control strategies wi

18 e-wide chromatin modification data, there is a pressing need for computational methods to analyze the

19 There is a pressing need for context-appropriate, evidence-based

20 There is a pressing need for cross-disciplinary research with an

21 Due to their clinical importance, there is a pressing need for effective computational methods that

22 A pressing need for effective, tumor-specific chemothera

23 h-resolution cytometric methods have created a pressing need for efficient fluorescent labeling proce

24 enomic and postgenomic information, there is a pressing need for efficient, inexpensive strategies fo

25 There is a pressing need for further case-control studies of pote

26 ons of the existing published data, there is a pressing need for further Level I and II evidence in t

27 There is a pressing need for further research and clinical develo

28 Thus, there is a pressing need for identifying novel therapeutic target

29 tance is occurring in human pathogens causes a pressing need for improved diagnostic technologies aim

30 There is a pressing need for improved understanding of the effect

31 roughput data in public repositories creates a pressing need for integrative analysis of multiple dat

32 There is a pressing need for interactive bioinformatics tools tha

33 There is a pressing need for large, prospective studies of the fr

34 There is a pressing need for methods for finding overlapping sequ

35 There is a pressing need for methods that can reliably reconstruc

36 posed for global network alignment, there is a pressing need for methods that produce more accurate a

37 ies, social support, and rehabilitation, but a pressing need for more effective treatments and delive

38 Thus, there is a pressing need for more efficient processes.

39 Consequently, there is a pressing need for more objective biomarkers of diet fo

40 There is a pressing need for more-efficient trial designs for bio

41 There is a pressing need for new and validated screening instrume

42 for the treatment of advanced PCa, there is a pressing need for new anti-AR therapeutic avenues.

43 ture promise of gene therapy, there is still a pressing need for new antiarrhythmic drugs.

44 biotic resistance, and as a result, there is a pressing need for new antibacterial therapies that can

45 fying drugs for neurodegenerative disorders, a pressing need for new chemical entities endowed with I

46 There is a pressing need for new data structures to store raw seq

47 Consequently, there is a pressing need for new empirical studies of An. gambiae

48 There is a pressing need for new inotropic agents that avoid thes

49 There is a pressing need for new technologies that improve the ef

50 There is a pressing need for new therapeutics to combat multidrug

51 are of limited effectiveness; thus, there is a pressing need for new therapies for this disease.

52 Thus, there is a pressing need for newer, more effective treatment stra

53 There is a pressing need for novel and innovative therapeutic str

54 se is often of limited benefit, and there is a pressing need for novel approaches in treatment of pat

55 g lag times for vaccine development, raising a pressing need for novel pharmacologic strategies that

56 Thus, there is a pressing need for novel strategies that mitigate this

57 e treatment for advanced disease, suggesting a pressing need for novel therapeutic approaches.

58 ally succumb to their disease, demonstrating a pressing need for novel therapeutic options.

59 There is a pressing need for novel, non-beta-lactam inhibitors of

60 There is a pressing need for objective non-invasive approaches to

61 Because of this, there is a pressing need for potent therapeutics that can either

62 There is a pressing need for randomized clinical trials evaluatin

63 There is a pressing need for randomized controlled trials to be p

64 There is a pressing need for rapid and reliable approaches to the

65 g global tuberculosis epidemic, and there is a pressing need for research focused on understanding an

66 importance and application of OPBS, there is a pressing need for robust comparative studies, includin

67 There is a pressing need for similar prospective studies to provi

68 NOACs in comparison with warfarin, there is a pressing need for strategies to manage bleeding when i

69 Thus, there is a pressing need for the development of analytical strate

70 gnificant threat to cancer patients, raising a pressing need for the development of effective strateg

71 Consequently, there is a pressing need for the development of methods that allo

72 alth of the world's population, and there is a pressing need for the development of new treatments an

73 There is a pressing need for the development of novel adjuvants f

74 There is a pressing need for the development of standard and refe

75 pathogenic avian influenza (HPAI), there is a pressing need for the development of vaccines that all

76 s of Zika virus (ZIKV) infections has become a pressing need for the effective prevention and control

77 This has in turn given rise to a pressing need for tools to simplify the analysis of th

78 There is thus a pressing need for tools to support the process of auto